Bristol-Myers Squibb Company (BMY) Stock Analysis
Bristol-Myers Squibb Company (BMY) is a publicly traded company in the HEALTHCARE sector. It trades at $54.46, carries a market capitalization of $112.21B, a price-to-earnings ratio of 15.39, a dividend yield of 0.04%. This page summarizes the public market data, fundamentals, and frequently asked questions for BMY, with GNG Research's proprietary safety, quality, and valuation analysis available to members.
Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL
Exchange: NYSE
Key Metrics
- Price: $54.46
- Market Cap: $112.21B
- P/E Ratio: 15.39
- EPS: $3.57
- Dividend Yield: 0.04%
- 52-Week High: $62.25
- 52-Week Low: $41.46
Market Sentiment
Bristol-Myers Squibb Company currently has a Bullish sentiment score of 0.25.
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (BMY) is a prominent global biopharmaceutical leader headquartered in New York City, renowned for its innovation in the discovery and delivery of transformative medicines. With a strategic focus on key therapeutic areas such as oncology, cardiovascular disease, immunology, and hematology, the company boasts a diverse portfolio that includes several well-established, market-leading therapies. BMS's dedication to addressing significant unmet medical needs, coupled w...
GNG Research Analysis
GNG Research scores Bristol-Myers Squibb Company (BMY) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BMY.
Frequently Asked Questions
What is BMY's current dividend yield?
Bristol-Myers Squibb Company (BMY) has a current dividend yield of 0.04%.
Does BMY pay dividends?
Yes, Bristol-Myers Squibb Company pays dividends with a current yield of 0.04%.
What is BMY's P/E ratio?
Bristol-Myers Squibb Company has a price-to-earnings (P/E) ratio of 15.39.
What is BMY's market cap?
Bristol-Myers Squibb Company (BMY) has a market capitalization of $112.21B with a current stock price of $54.46.